Interleukin-17A Deficiency Attenuated Emphysema and Bone Loss in Mice Exposed to Cigarette Smoke

References

• VogelmeierCF, CrinerGJ, MartinezFJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP28128970
   PubMed Web of Science ®Google Scholar
• BiskobingDM. COPD and osteoporosis. Chest. 2002;121(2):609–620. doi:10.1378/chest.121.2.60911834678
   PubMed Web of Science ®Google Scholar
• HillasG, PerlikosF, TsiligianniI, TzanakisN. Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:95–109. doi:10.2147/COPD.S5447325609943
   PubMed Web of Science ®Google Scholar
• SmithMC, WrobelJP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:871–888. doi:10.2147/COPD25210449
   PubMed Web of Science ®Google Scholar
• Nussbaumer-OchsnerY, RabeKF. Systemic manifestations of COPD. Chest. 2011;139(1):165–173. doi:10.1378/chest.10-125221208876
   PubMed Web of Science ®Google Scholar
• SindenNJ, StockleyRA, LEEJ-H. Systemic inflammation and comorbidity in COPD: a result of ‘overspill’ of inflammatory mediators from the lungs? Review of the evidence. Thorax. 2010;65(10):930–936. doi:10.1136/thx.2009.13026020627907
   PubMed Web of Science ®Google Scholar
• BarnesPJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27. doi:10.1016/j.jaci.2016.05.01127373322
   PubMed Web of Science ®Google Scholar
• KongYY, FeigeU, SarosiI, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999;402(6759):304–309. doi:10.1038/4630310580503
   PubMed Web of Science ®Google Scholar
• SatoK, SuematsuA, OkamotoK, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006;203(12):2673–2682. doi:10.1084/jem.2006177517088434
   PubMed Web of Science ®Google Scholar
• ChenY, BaiP, LiuL, HanJ, ZengH, SunY. Increased RANKL expression in peripheral T cells is associated with decreased bone mineral density in patients with COPD. Int J Mol Med. 2016;38(2):585–593. doi:10.3892/ijmm.2016.262927279356
   PubMed Web of Science ®Google Scholar
• DuanMC, ZhangJQ, LiangY, et al. Infiltration of IL-17-producing T cells and treg cells in a mouse model of smoke-induced emphysema. Inflammation. 2016;39(4):1334–1344. doi:10.1007/s10753-016-0365-827150336
   PubMed Web of Science ®Google Scholar
• ChenK, PociaskDA, McAleerJP, et al. IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS One. 2011;6(5):e20333. doi:10.1371/journal.pone.002033321647421
   PubMed Web of Science ®Google Scholar
• Di StefanoA, CaramoriG, GnemmiI, et al. T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol. 2009;157(2):316–324. doi:10.1111/cei.2009.157.issue-219604272
   PubMed Web of Science ®Google Scholar
• EustaceA, SmythL, MitchellL, WilliamsonK, PlumbJ, SinghD. Identification of cells expressing IL-17A and IL-17F in the lungs of patients with COPD. Chest. 2011;139(5):1089–1100. doi:10.1378/chest.10-077920864612
   PubMed Web of Science ®Google Scholar
• ChangY, Al-AlwanL, AudusseauS, et al. Genetic deletion of IL-17A reduces cigarette smoke-induced inflammation and alveolar type II cell apoptosis. Am J Physiol Lung Cell Mol Physiol. 2014;306(2):L132–L143. doi:10.1152/ajplung.00111.201324097560
   PubMed Web of Science ®Google Scholar
• ShanM, YuanX, SongLZ, et al. Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysema. Sci Transl Med. 2012;4(117):117–119. doi:10.1126/scitranslmed.3003041
   Web of Science ®Google Scholar
• KotakeS, UdagawaN, TakahashiN, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. 1999;103(9):1345–1352. doi:10.1172/JCI570310225978
   PubMed Web of Science ®Google Scholar
• MilanovaV, IvanovskaN, DimitrovaP. TLR2 elicits IL-17-mediated RANKL expression, IL-17, and OPG production in neutrophils from arthritic mice. Mediators Inflamm. 2014;2014:643406. doi:10.1155/2014/64340624757287
   PubMed Web of Science ®Google Scholar
• LeeY. The role of interleukin-17 in bone metabolism and inflammatory skeletal diseases. BMB Rep. 2013;46(10):479–483. doi:10.5483/BMBRep.2013.46.10.14124148767
   PubMed Web of Science ®Google Scholar
• SasakiM, ChubachiS, KameyamaN, et al. Effects of long-term cigarette smoke exposure on bone metabolism, structure, and quality in a mouse model of emphysema. PLoS One. 2018;13(1):e191611. doi:10.1371/journal.pone.0191611
   Web of Science ®Google Scholar
• KoCH, ChanRL, SiuWS, et al. Deteriorating effect on bone metabolism and microstructure by passive cigarette smoking through dual actions on osteoblast and osteoclast. Calcif Tissue Int. 2015;96(5):389–400. doi:10.1007/s00223-015-9966-825694359
   PubMed Web of Science ®Google Scholar
• ZhouL, LeY, TianJ, et al. Cigarette smoke-induced RANKL expression enhances MMP-9 production by alveolar macrophages. Int J Chron Obstruct Pulmon Dis. 2019;14:81–91. doi:10.2147/COPD.S19002330587964
   PubMed Web of Science ®Google Scholar
• BrackeKR, D’HulstAI, MaesT, et al. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. J Immunol. 2006;177(7):4350–4359. doi:10.4049/jimmunol.177.7.435016982869
   PubMed Web of Science ®Google Scholar
• SreenivasanD, TuPT, DickinsonM, et al. Computer modelling integrated with micro-CT and material testing provides additional insight to evaluate bone treatments: application to a beta-glycan derived whey protein mice model. Comput Biol Med. 2016;68:9–20. doi:10.1016/j.compbiomed.2015.10.01726599826
   PubMed Web of Science ®Google Scholar
• ZhenG, WenC, JiaX, et al. Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med. 2013;19(6):704–712. doi:10.1038/nm.314323685840
   PubMed Web of Science ®Google Scholar
• TanakaY, NakayamadaS, OkadaY. Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr Drug Targets Inflamm Allergy. 2005;4(3):325–328. doi:10.2174/156801005402201516101541
   PubMedGoogle Scholar
• TanakaS, TanakaY, IshiguroN, YamanakaH, TakeuchiT. RANKL: a therapeutic target for bone destruction in rheumatoid arthritis. Mod Rheumatol. 2018;28(1):9–16. doi:10.1080/14397595.2017.136949128880683
   PubMed Web of Science ®Google Scholar
• BaiP, SunY, JinJ, et al. Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. Respir Res. 2011;12:157. doi:10.1186/1465-9921-12-15722176920
   PubMed Web of Science ®Google Scholar
• GinaldiL, Di BenedettoMC, De MartinisM. Osteoporosis, inflammation and ageing. Immun Ageing. 2005;2:14. doi:10.1186/1742-4933-2-1416271143
   PubMedGoogle Scholar
• RoosAB, SandenC, MoriM, BjermerL, StampfliMR, ErjefaltJS. IL-17A Is elevated in end-stage chronic obstructive pulmonary disease and contributes to cigarette smoke-induced lymphoid neogenesis. Am J Respir Crit Care Med. 2015;191(11):1232–1241.25844618
   PubMed Web of Science ®Google Scholar
• RoosAB, StampfliMR. Targeting interleukin-17 signalling in cigarette smoke-induced lung disease: mechanistic concepts and therapeutic opportunities. Pharmacol Therapeut. 2017;178:123–131. doi:10.1016/j.pharmthera.2017.04.001
   PubMed Web of Science ®Google Scholar
• Graat-VerboomL, WoutersEF, SmeenkFW, van den BorneBE, LundeR, SpruitMA. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J. 2009;34(1):209–218. doi:10.1183/09031936.5013040819567604
   PubMed Web of Science ®Google Scholar
• LehouckA, BoonenS, DecramerM, JanssensW. COPD, bone metabolism, and osteoporosis. Chest. 2011;139(3):648–657. doi:10.1378/chest.10-142721362651
   PubMed Web of Science ®Google Scholar
• BonJ, FuhrmanCR, WeissfeldJL, et al. Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. Am J Respir Crit Care Med. 2011;183(7):885–890. doi:10.1164/rccm.201004-0666OC20935108
   PubMed Web of Science ®Google Scholar
• TsukamotoM, MoriT, WangKY, et al. Systemic bone loss, impaired osteogenic activity and type I muscle fiber atrophy in mice with elastase-induced pulmonary emphysema: establishment of a COPD-related osteoporosis mouse model. Bone. 2019;120:114–124. doi:10.1016/j.bone.2018.10.01730342225
   PubMed Web of Science ®Google Scholar
• RachnerTD, KhoslaS, HofbauerLC. Osteoporosis: now and the future. Lancet. 2011;377(9773):1276–1287. doi:10.1016/S0140-6736(10)62349-521450337
   PubMed Web of Science ®Google Scholar
• YoonV, MaaloufNM, SakhaeeK. The effects of smoking on bone metabolism. Osteoporos Int. 2012;23(8):2081–2092. doi:10.1007/s00198-012-1940-y22349964
   PubMed Web of Science ®Google Scholar
• VegaD, MaaloufNM, SakhaeeK. Clinical review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications. J Clin Endocrinol Metab. 2007;92(12):4514–4521. doi:10.1210/jc.2007-064617895323
   PubMed Web of Science ®Google Scholar
• LeibbrandtA, PenningerJM. RANK/RANKL: regulators of immune responses and bone physiology. Ann N Y Acad Sci. 2008;1143:123–150. doi:10.1196/nyas.2008.1143.issue-119076348
   PubMed Web of Science ®Google Scholar
• KitamiS, TanakaH, KawatoT, et al. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells. Biochimie. 2010;92(4):398–404. doi:10.1016/j.biochi.2009.12.01120045440
   PubMed Web of Science ®Google Scholar
• AdamopoulosIE, ChaoCC, GeisslerR, et al. Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors. Arthritis Res Ther. 2010;12(1):R29. doi:10.1186/ar293620167120
   PubMed Web of Science ®Google Scholar
• LubbertsE, KoendersMI, Oppers-WalgreenB, et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 2004;50(2):650–659. doi:10.1002/(ISSN)1529-013114872510
   PubMed Web of Science ®Google Scholar
• BraunT, SchettG. Pathways for bone loss in inflammatory disease. Curr Osteoporos Rep. 2012;10(2):101–108. doi:10.1007/s11914-012-0104-522527726
   PubMed Web of Science ®Google Scholar
• GeesalaR, DhokeNR, DasA. Cox-2 inhibition potentiates mouse bone marrow stem cell engraftment and differentiation-mediated wound repair. Cytotherapy. 2017;19(6):756–770. doi:10.1016/j.jcyt.2017.03.07228433514
   PubMed Web of Science ®Google Scholar
• LeeJH, ChoML, KimJI, et al. Interleukin 17 (IL-17) increases the expression of Toll-like receptor-2, 4, and 9 by increasing IL-1beta and IL-6 production in autoimmune arthritis. J Rheumatol. 2009;36(4):684–692. doi:10.3899/jrheum.08016919228664
   PubMed Web of Science ®Google Scholar
• IqbalJ, SunL, CaoJ, et al. Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes. Proc Natl Acad Sci U S A. 2013;110(27):11115–11120. doi:10.1073/pnas.122091911023776235
   PubMed Web of Science ®Google Scholar